HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03435302 |
|
Recruitment Status : Unknown
Verified February 2018 by Lu Si, Beijing Cancer Hospital.
Recruitment status was: Recruiting
First Posted : February 19, 2018
Last Update Posted : February 19, 2018
|
Sponsor:
Beijing Cancer Hospital
Information provided by (Responsible Party):
Lu Si, Beijing Cancer Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | February 2018 |
| Estimated Study Completion Date : | February 2019 |